Thyroid Eye Disease, TED: Clinical Trials

1 trial for Thyroid Eye Disease, TED, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Thyroid Eye Disease, TED: new trials by email Literature Review of Thyroid Eye Disease, TED trials Research Report on Thyroid Eye Disease, TED

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease
IBI311 - Thyroid Eye Disease, TED
Phase 3CompletedInnovent Biologics (Suzhou) Co. Ltd.912023-10-202026-05-01

Narrower conditions

Graves Ophthalmopathy (1)

Broader conditions

Autoimmune Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Endocrine System Diseases (1)  ·  Exophthalmos (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Goiter (1)  ·  Graves Disease (1)  ·  Hyperthyroidism (1)  ·  Immune System Diseases (1)  ·  Orbital Diseases (1)  ·  Thyroid Diseases (1)

Sponsors

Innovent Biologics (Suzhou) Co. Ltd. (1)

Countries

China (1)